ATS: Heart valve results confirm low complication rates

By Elaine Rigoli

Tampa, Fla., Sept. 21 - ATS Medical, Inc. said mid-term clinical results from an 11-year, 600-patient study of the ATS Open Pivot Heart Valve confirm earlier studies reporting outstanding clinical performance and low-complication rates.

According to a company news release, the study noted that some patients used international normalized ratio home monitoring for management of anticoagulation and that such monitoring led to "better targeting of the anticoagulation corridor, which may therefore present additional health benefits for the patient cohort."

The Minneapolis-based cardiac therapy company recently announced its partnership with the leading provider of international normalized ratio home monitoring services, Quality Assured Services, Inc.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.